ArticleExperimental hematology & oncology2024

CD19/CD22 CAR-T-cell cocktail therapy following autologous transplantation is an optimizing strategy for treating relapsed/refractory central nervous system lymphoma.

Xiaoxi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.